We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
The 2026 National Health and Medical Research Council (NHMRC) Global Alliance for Chronic Diseases (GACD) grant opportunity focuses on implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system to tackle chronic non-communicable diseases in underserved populations.
Together with other GACD Associate Members, NHMRC invites investigators to submit implementation research proposals focused on strategies leveraging opportunities provided by settings and sectors beyond the health system in low- and middle-income countries (LMICs) and/or for Aboriginal and/or Torres Strait Islander communities in Australia. While the focus is on settings outside of the healthcare system, collaboration with the relevant healthcare system(s) as part of the project is expected to facilitate effective design and knowledge mobilisation.
Additional funding may be available for applications which support:
Further details of the funding call and guidance documents can be found on the GACD website.
For joint funding applications to GACD which request funds from NHMRC as a secondary funding agency, an Australia-based lead investigator must be identified within the research team of the Stage 1 GACD proposal to lead the NHMRC-funded components of the proposal. The Australia-based lead investigator must meet the NHMRC Chief Investigator A eligibility requirements and will be responsible for fulfilling the obligations and requirements of Chief Investigator A outlined at sections 7.7 and 10.3 of the 2026 NHMRC-GACD Guidelines.
Applicants can be named as a Chief Investigator A on a maximum of one application for the 2026 NHMRC-GACD Multisectoral Approaches funding call.